Changes in characteristics and management among patients with ST-elevation myocardial infarction due to COVID-19 infection.
Batric PopovicJeanne VarlotPierre Adrien MetzdorfHélène JeulinFrançois GoehringerEdoardo CamenzindPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
The COVID-19 outbreak implies deep changes in the etiopathogenesis and therapeutic management of STEMI patients with COVID-19. The impact on early and long-term outcomes of systemic inflammation and hypercoagulability in this specific population is warranted.